ZA894800B - Proteins and nucleic acids - Google Patents

Proteins and nucleic acids

Info

Publication number
ZA894800B
ZA894800B ZA894800A ZA894800A ZA894800B ZA 894800 B ZA894800 B ZA 894800B ZA 894800 A ZA894800 A ZA 894800A ZA 894800 A ZA894800 A ZA 894800A ZA 894800 B ZA894800 B ZA 894800B
Authority
ZA
South Africa
Prior art keywords
proteins
nucleic acids
nucleic
acids
Prior art date
Application number
ZA894800A
Other languages
English (en)
Inventor
Richard Mark Edwards
Mark Edwards Richard
Anthony Fallon
Fallon Anthony
Keith Dawson
Dawson Keith
Stewart Craig
Craig Stewart
Original Assignee
British Bio Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Bio Technology filed Critical British Bio Technology
Publication of ZA894800B publication Critical patent/ZA894800B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B4/00—Electrothermal treatment of ores or metallurgical products for obtaining metals or alloys
    • C22B4/02—Light metals
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22B—PRODUCTION AND REFINING OF METALS; PRETREATMENT OF RAW MATERIALS
    • C22B4/00—Electrothermal treatment of ores or metallurgical products for obtaining metals or alloys
    • C22B4/06—Alloys
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C1/00—Making non-ferrous alloys
    • C22C1/02—Making non-ferrous alloys by melting
    • C22C1/026—Alloys based on aluminium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00—Technologies related to metal processing
    • Y02P10/20—Recycling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Geology (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Environmental & Geological Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA894800A 1988-06-24 1989-06-23 Proteins and nucleic acids ZA894800B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888815135A GB8815135D0 (en) 1988-06-24 1988-06-24 Proteins & nucleic acids

Publications (1)

Publication Number Publication Date
ZA894800B true ZA894800B (en) 1990-05-30

Family

ID=10639339

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894800A ZA894800B (en) 1988-06-24 1989-06-23 Proteins and nucleic acids

Country Status (15)

Country Link
US (1) US5232847A (pt)
EP (1) EP0352904A1 (pt)
JP (1) JPH03505524A (pt)
KR (1) KR900702018A (pt)
AU (1) AU627475B2 (pt)
DK (1) DK305490A (pt)
FI (1) FI906322A0 (pt)
GB (1) GB8815135D0 (pt)
HU (1) HUT61593A (pt)
IL (1) IL90745A0 (pt)
NO (1) NO905561L (pt)
NZ (1) NZ229691A (pt)
PT (1) PT90976A (pt)
WO (1) WO1989012681A1 (pt)
ZA (1) ZA894800B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5346824A (en) * 1988-05-20 1994-09-13 Genentech, Inc. DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
JPH0595786A (ja) * 1991-10-07 1993-04-20 Green Cross Corp:The 変異ヒトプロウロキナーゼ
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) * 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins
GB8608014D0 (en) * 1986-04-02 1986-05-08 Beecham Group Plc Compounds
PT84587B (pt) * 1986-04-02 1989-11-30 Beecham Group Plc Processo para preparacao de uma enzima fibrinolitica
PT84589B (en) * 1986-04-02 1989-05-09 Beecham Group Plc Process for preparing a fibrinolytic enzyme
DK302388A (da) * 1987-06-04 1989-02-03 Zymogenetics Inc T-pa analoger med dodificeret vaekstfaktordomaene
AU613942B2 (en) * 1987-06-30 1991-08-15 Genentech Inc. Improved processes for the treatment of vascular disease
JPH03500002A (ja) * 1987-07-06 1991-01-10 ジェネティックス・インスチチュート・インコーポレーテッド 新規な血栓崩壊蛋白
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
JPH02273179A (ja) * 1988-12-12 1990-11-07 Yamanouchi Pharmaceut Co Ltd 新規な血栓溶解蛋白質，その製造法および該蛋白質からなる医薬

Also Published As

Publication number Publication date
WO1989012681A1 (en) 1989-12-28
HU893786D0 (en) 1991-05-28
NZ229691A (en) 1992-03-26
FI906322A0 (fi) 1990-12-20
HUT61593A (en) 1993-01-28
NO905561L (no) 1991-02-22
PT90976A (pt) 1989-12-29
DK305490A (da) 1991-02-20
DK305490D0 (da) 1990-12-21
AU3838189A (en) 1990-01-12
EP0352904A1 (en) 1990-01-31
US5232847A (en) 1993-08-03
NO905561D0 (no) 1990-12-21
KR900702018A (ko) 1990-12-05
IL90745A0 (en) 1990-03-19
JPH03505524A (ja) 1991-12-05
GB8815135D0 (en) 1988-08-03
AU627475B2 (en) 1992-08-27

Similar Documents

Publication Publication Date Title
PH25327A (en) Binfunctional proteins
GB8823068D0 (en) Recombinant dna
ZA894800B (en) Proteins and nucleic acids
GB8802508D0 (en) Detection of mutations in nucleic acids
IL87730A0 (en) Peptides and antibodies
GB2233557A (en) Cyto-photo-protector agent based on nucleic acids and/or their derivatives
GB9023149D0 (en) Proteins and nucleic acids
GB8817160D0 (en) Novel proteins
IL91335A0 (en) Dna sequence and hepadnavirus
IL86153A0 (en) Recombinant htlv-iii proteins and uses thereof
GB8817161D0 (en) Modified proteins
GB2257891B (en) Pre-dusting protein products
ZA921892B (en) Proteins and nucleic acids
GB8816095D0 (en) Protein
GB8921227D0 (en) Antibodies and proteins
GB9116325D0 (en) Proteins and nucleic acids
GB9202401D0 (en) Proteins and nucleic acids
GB9217881D0 (en) Protein and nucleic acids
GB9512092D0 (en) Proteins and nucleic acids
GB8827157D0 (en) Sequencing nucleic acids
GB8820365D0 (en) Recombinant dna proteins
SG63583A1 (en) 7-substituted-hept-6-enoic and - heptanoic acids and derivatives thereof
IE882901L (en) Protein assay device and method
GB2210164B (en) Protein assay device and method
ZA895536B (en) Peptide and dna sequences